CLASS II ONGOING Device recall · Reported 26 May 2021 · FDA Enforcement Report

Medtronic REF: Mmt-7020C4 Guardian Sensor (3) for the following recalled

Medtronic is recalling Medtronic REF: Mmt-7020C4 Guardian Sensor (3) for the following. The recall was initiated on 26 Feb 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lot numbers within active shelf life
Quantity recalled54,211 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1610-2021
FDA event ID
87476
Recalling firm
Medtronic, Northridge, CA
Classification
Class II
Status
Ongoing
Recall initiated
26 Feb 2021
FDA classified
17 May 2021
Reported
26 May 2021
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Labeling Errors

Timeline

26 Feb 2021Recall initiated by company
17 May 2021Classified by FDA+80 days
26 May 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Use of the continuous glucose monitoring system while actively taking hydroxyurea, an anti-neoplastic drug could result in inaccurate elevated sensor glucose readings.

Product as listed by the FDA

Medtronic REF: MMT-7020C4 Guardian Sensor (3) for the following packaging: GS3 5PK 2L CANADA/ GTIN: 20763000179612 Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes. *Product not distributed within US.

Where it was distributed

Worldwide distribution.

Questions about this recall

Is Medtronic REF: Mmt-7020C4 Guardian Sensor (3) for the following recalled?

Yes. Medtronic recalled Medtronic REF: Mmt-7020C4 Guardian Sensor (3) for the following on 26 Feb 2021. The recall is Class II and its status is Ongoing. Recall number Z-1610-2021.

Why was it recalled?

Use of the continuous glucose monitoring system while actively taking hydroxyurea, an anti-neoplastic drug could result in inaccurate elevated sensor glucose readings.

Which lots are affected?

All Lot numbers within active shelf life

Where was it sold?

Worldwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic

All 148

Other Insulin Pumps & Glucose Monitors recalls

All 459